4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-16-090629
CIK 0001373707operating
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:35 PM ET
Size
8.0 KB
Accession
0001209191-16-090629
Insider Transaction Report
Form 4
Horn Patrick Taylor
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2016-01-06+100,000→ 100,000 totalExercise: $8.47Exp: 2026-01-05→ Common Stock (100,000 underlying) - Award
Restricted Stock Units
2016-01-06+35,000→ 35,000 totalExercise: $0.00→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]Vests as to 6.25% of the shares on 4/6/2016 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/6/2020.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F3]The restricted stock units vest in three equal installments on each of January 6, 2017, January 6, 2018 and January 6, 2019.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 6:35 PM ET
- Size
- 8.0 KB